Anxiety
Study Unveils Opposing Impacts of Anxiety and Apathy on Decision-Making Under Uncertainty
2025-03-06
The Renaissance of Psychedelics Research: An Interview with the CEO of MindMed, Rob Barrow
2022-04-12
From Forbidden Drugs to Psychotropic Cures: A “Psychedelic Boom” Breaks New Ground in Treating Mental Illnesses
2022-03-08
Mental Healthcare Startup Cerebral Valued at $4.8 Billion after $300 Million Softbank-led Series C
2021-12-10
LATEST
Study Finds Treatment Variations in Immunobullous Disorders Linked to Demographic Factors
2026-01-24
Study Finds Orexin Receptor Agonists May Pose Higher Fracture Risk Compared to Melatonin Receptor Agonists
2026-01-24
Researchers Develop Distributed Method Using Control Barrier Functions to Enhance Network Connectivity
2026-01-24



